Arginine depletion as a therapeutic approach for patients with COVID-19

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a source of significant morbidity and death worldwide, and effective treatments are urgently needed. Clinical trials have focused largely on direct antiviral therapies or on immunomodulation in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimes, Joseph M., Khan, Shaheer, Badeaux, Mark, Rao, Ravi M., Rowlinson, Scott W., Carvajal, Richard D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641537/
https://www.ncbi.nlm.nih.gov/pubmed/33160064
http://dx.doi.org/10.1016/j.ijid.2020.10.100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641537/
https://www.ncbi.nlm.nih.gov/pubmed/33160064
http://dx.doi.org/10.1016/j.ijid.2020.10.100

Ejemplares similares